本子基金的目標是透過主要投資於被認為增長前景優於平均水平及盈利增長相對穩定的美國企業的普通股，以達致中期資產增值。團隊的增長股理念強調使用基本 因素估值技術，有關技術專注於企業的未來盈利和股息增長率。該投資程序主要是「由下而上」的程序，並使用一個現行估值模型。該模型分析股票的現價，與企 業的估計未來盈利來源的經風險調整現值之間的相關性。公司尋求買入售價較公平價值折讓的增長股，以及在每股盈利可望於中期顯著增長時進行購買。
Chris Fay joined BNP Paribas Asset Management in 2013 from Pioneer Investment Management in Boston where he was a portfolio manager and analyst covering the global health care sector. Prior to that, he was an institutional healthcare consultant with Leerink Swann & Co. and Kendall Strategies Inc. Earlier in his career he was employed by The Massachusetts Department of Public Health as the Chief of Administration and Finance. Chris earned his B.A. from the George Washington University. He received a M.S. in Biology from Loyola University of Chicago, a Masters in Public Health from Boston University and an M.B.A. from the Carroll School of Management, Boston College.
Pamela is the Head of the US Equities team at BNP Paribas Asset Management. Pamela was a Portfolio Manager and Analyst focusing on Consumer Discretionary before becoming the head of team in 2013. She joined us in 2004 and is based in Boston. Pamela is the most experienced and longest tenured member of the team. Prior to her current responsibilities, Pamela was Portfolio Manager for Consumer Discretionary. Prior to joining us, she was Vice President, Senior Equity Analyst and Global Sector Manager at Wellington Management. During her time there, she had specific responsibility for global consumer stocks. Prior to that, she was a Vice President, Equity Analyst at Evergreen Investments, and a Vice President, Industry Analyst at Merrill Lynch. She began her career as a Senior Tax Associate at Coopers & Lybrand in 1988. Pamela has over 25 years of investment experience. She earned her BS from the University of California, Berkeley and her MBA from Harvard Business School.